Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-17 5:01 pm Purchase | 13D | Monopar Therapeutics MNPR | Tactic Pharma LLC | 1,037,396 19.200% | 1,037,396 (New Position) | View |
| 2024-11-06 3:13 pm Purchase | 13G | Monopar Therapeutics MNPR | JANUS HENDERSON GROUP PLC JHG | 562,482 10.900% | 562,482 (New Position) | View |
| 2024-10-31 4:17 pm Purchase | 13G | Monopar Therapeutics MNPR | RA CAPITAL MANAGEMENT L.P. | 511,207 9.700% | 511,207 (New Position) | View |
| 2024-10-28 06:00 am Purchase | 13G | Monopar Therapeutics MNPR | ASTRAZENECA PLC AZN | 387,329 9.900% | 387,329 (New Position) | View |
| 2024-10-24 4:08 pm Purchase | 13G | Monopar Therapeutics MNPR | TANG CAPITAL MANAGEMENT LLC | 200,000 5.100% | 200,000 (New Position) | View |
| 2023-06-02 4:57 pm Purchase | 13G | Monopar Therapeutics MNPR | Klunzinger Jeffrey R. | 692,800 5.240% | 692,800 (New Position) | View |
| 2019-12-23 09:05 am Purchase | 13D | Tactic Pharma LLC MNPR | Monopar Therapeutics MNPR | 4,660,064 44.000% | 1,135,920 (+32.23%) | View |
| 2019-12-23 09:05 am Purchase | 13D | MONOPAR THERAPEUTICS INC MNPR | Monopar Therapeutics MNPR | 3,524,144 33.000% | 3,524,144 (New Position) | View |